Status: Recruiting
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Study to evaluate the safety and tolerability of single ascending doses of brexpiprazole long-acting injection in healthy subjects/patients with schizophrenia.
Participants needed: 56
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Sichuan Kelun Pharmaceutical Co.,Ltd.Updated: Jun 29, 2026Locations: 1
Eligibility criteria
Male and female subjects aged 18 to 65 years (including) at the time of signing... [+11]
History of cardiovascular system (such as history of ischemic heart disease), en... [+49]